|
1
|
Feuer EJ, Wun LM, Boring CC, Flanders WD,
Timmel MJ and Tong T: The lifetime risk of developing breast
cancer. J Natl Cancer Inst. 85:892–897. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
So WK, Choi KC, Chan CW and Chair SY:
Age-related differences in the quality of life of Chinese women
undergoing adjuvant therapy for breast cancer. Res Gerontol Nurs.
29–26. 2011.
|
|
3
|
Zhu D, Lam DH, Purwanti YI, Goh SL, Wu C,
Zeng J, Fan W and Wang S: Systemic delivery of fusogenic membrane
glycoprotein-expressing neural stem cells to selectively kill tumor
cells. Mol Ther. 21:1621–1630. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Luo M, Clouthier SG, Deol Y, Liu S,
Nagrath S, Azizi E and Wicha MS: Breast cancer stem cells: Current
advances and clinical implications. Methods Mol Biol. 1293:1–49.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Hyvönen M and Laakkonen P: Identification
and characterization of homing peptides using in vivo peptide phage
display. Methods Mol Biol. 1324:205–222. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Tiede C, Tang AA, Deacon SE, Mandal U,
Nettleship JE, Owen RL, George SE, Harrison DJ, Owens RJ, Tomlinson
DC and McPherson MJ: Adhiron: A stable and versatile peptide
display scaffold for molecular recognition applications. Protein
Eng Des Sel. 27:145–55. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Ajani JA, Song S, Hochster HS and
Steinberg IB: Cancer stem cells: The promise and the potential.
Semin Oncol. 42 (Suppl 1):S3–S17. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Li X and Mao C: Using phage as a platform
to select cancer cell-targeting peptides. Methods Mol Biol.
1108:57–68. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Wang T, Hartner WC, Gillespie JW, Praveen
KP, Yang S, Mei LA, Petrenko VA and Torchilin VP: Enhanced tumor
delivery and antitumor activity in vivo of liposomal doxorubicin
modified with MCF-7-specific phage fusion protein. Nanomedicine.
10:421–430. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Pouyanfard S, Bamdad T, Hashemi H,
Bandehpour M and Kazemi B: Induction of protective anti-CTL epitope
responses against HER-2-positive breast cancer based on multivalent
T7 phage nanoparticles. PLoS One. 7:e495392012. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Finlay-Schultz J, Cittelly DM, Hendricks
P, Patel P, Kabos P, Jacobsen BM, Richer JK and Sartorius CA:
Progesterone downregulation of miR-141 contributes to expansion of
stem-like breast cancer cells through maintenance of progesterone
receptor and Stat5a. Oncogene. 34:3676–3687. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Lv YG, Wang T, Yuan SF, Li NL, Chen JH,
Zhao AZ, Ling R and Wang L: T-vector and in vivo recombination as
tools to construct a large antibody library of breast cancer.
Hybridoma (Larchmt). 29:251–254. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Petrenko VA and Jayanna PK: Phage
protein-targeted cancer nanomedicines. FEBS Lett. 588:341–349.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Park HY, Lee KJ, Lee SJ and Yoon MY:
Screening of peptides bound to breast cancer stem cell specific
surface marker CD44 by phage display. Mol Biotechnol. 51:212–220.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Nemudraya AA, Kuligina EV, Ilyichev AA,
Fomin AS, Stepanov GA, Savelyeva AV, Koval OA and Richter VA:
Selection of antitumor displayed peptides for the specific delivery
of the anticancer drug lactaptin. Oncol Lett. 12:4547–4555. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Yang H, Brand JS, Fang F, Chiesa F,
Johansson AL, Hall P and Czene K: Time-dependent risk of
depression, anxiety, and stress-related disorders in patients with
invasive and in situ breast cancer. Int J Cancer. 140:841–852.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Yang F, Xu J, Tang L and Guan X: Breast
cancer stem cell: The roles and therapeutic implications. Cell Mol
Life Sci. 74:951–966. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Asad AS, Moreno Ayala MA, Gottardo MF,
Zuccato C, Nicola Candia AJ, Zanetti FA, Seilicovich A and Candolfi
M: Viral gene therapy for breast cancer: Progress and challenges.
Exp Opin Biol Ther. 17:945–959. 2017. View Article : Google Scholar
|
|
19
|
Alferez DG, Simões BM, Howell SJ and
Clarke RB: The role of steroid hormones in breast and effects on
cancer stem cells. Curr Stem Cell Rep. 4:81–94. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Wolfe AR and Woodward WA: Breast cancer
stem cell correlates as Predicative factors for radiation therapy.
Semin Radiat Oncol. 25:251–259. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
To K, Fotovati A, Reipas KM, Law JH, Hu K,
Wang J, Astanehe A, Davies AH, Lee L, Stratford AL, et al: Y-box
binding protein-1 induces the expression of CD44 and CD49f leading
to enhanced self-renewal, mammo-sphere growth, and drug resistance.
Cancer Res. 70:2840–2851. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Liu F, Qi CL, Kong M, Liu TT, Li L and Li
BJ: Screening specific polypeptides of breast cancer stem cells
from a phage display random peptide library. Oncol Lett.
12:4727–4731. 2016. View Article : Google Scholar : PubMed/NCBI
|
